Generation bio names phillip samayoa, ph.d. chief strategy officer

Cambridge, mass., sept. 20, 2022 (globe newswire) -- generation bio co. (nasdaq: gbio), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announced the promotion of phillip samayoa, ph.d., to chief strategy officer. dr. samayoa has led strategy, corporate and portfolio development at generation bio since he joined the company in 2017, most recently serving as senior vice president.
GBIO Ratings Summary
GBIO Quant Ranking